痴呆症神经精神症状的药物治疗。
Pharmacotherapy of neuropsychiatric symptoms of dementia.
作者信息
Casey David A
出版信息
P T. 2015 Apr;40(4):284-7.
Abstract
Approximately 5 million Americans have dementia, and many receive psychiatric medications. Management of such patients is complex and controversial, and it has become apparent that all potential pharmacological therapies present risks.
摘要
约500万美国人患有痴呆症，其中许多人正在接受精神科药物治疗。对此类患者的管理复杂且存在争议，而且很明显，所有潜在的药物治疗都有风险。
相似文献
1
Pharmacotherapy of neuropsychiatric symptoms of dementia.痴呆症神经精神症状的药物治疗。
P T. 2015 Apr;40(4):284-7.
2
[Pharmacotherapy of neuropsychiatric symptoms in dementia in nursing homes: a comparison of service provision by psychiatric outpatient clinics and primary care psychiatrists].养老院中痴呆症神经精神症状的药物治疗：精神科门诊与基层医疗精神科医生服务提供情况的比较
Psychiatr Prax. 2010 May;37(4):196-8. doi: 10.1055/s-0029-1223475. Epub 2010 Mar 11.
3
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.痴呆症神经精神症状的药物治疗：证据综述
JAMA. 2005 Feb 2;293(5):596-608. doi: 10.1001/jama.293.5.596.
4
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA.痴呆患者的神经精神症状：美国药物治疗的考虑因素。
Drugs R D. 2019 Jun;19(2):93-115. doi: 10.1007/s40268-019-0272-1.
5
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.使用抗精神病药物与其他精神科药物治疗的痴呆患者的死亡风险。
Am J Psychiatry. 2007 Oct;164(10):1568-76; quiz 1623. doi: 10.1176/appi.ajp.2007.06101710.
6
Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress.痴呆行为和心理症状的药物治疗：现状与未来进展
Front Pharmacol. 2020 Jul 31;11:1168. doi: 10.3389/fphar.2020.01168. eCollection 2020.
7
Neuropsychiatric aspects of dementia.痴呆的神经精神方面
Maturitas. 2014 Oct;79(2):209-15. doi: 10.1016/j.maturitas.2014.04.005. Epub 2014 Apr 13.
8
Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms.老年痴呆症患者出现神经精神症状时急诊服务的管理。
Int J Geriatr Psychiatry. 2017 Dec;32(12):1233-1240. doi: 10.1002/gps.4599. Epub 2016 Oct 4.
9
Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.额颞叶痴呆精神症状的药物治疗：一项系统评价
J Geriatr Psychiatry Neurol. 2017 May;30(3):162-169. doi: 10.1177/0891988717700506. Epub 2017 Mar 28.
10
Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.用于治疗痴呆症神经精神症状的5-羟色胺能药物。
Expert Rev Neurother. 2016;16(4):375-87. doi: 10.1586/14737175.2016.1155453. Epub 2016 Mar 10.
引用本文的文献
1
Prevalence of Cognitive Impairment/Dementia and Associated Risks Factors Among Community-Dwelling Elderly People Aged 65 or Above in the Community Centers in Hong Kong: A Cross-Sectional Study.香港社区中心65岁及以上社区居住老年人认知障碍/痴呆的患病率及相关危险因素：一项横断面研究
Brain Behav. 2025 Mar;15(3):e70388. doi: 10.1002/brb3.70388.
2
Uncovering perspectives on physical activity in nursing homes: a qualitative exploration of the experiences of healthcare professionals and family caregivers.揭示养老院中身体活动的观点：医疗保健专业人员和家庭照护者的经验的定性探讨。
BMC Health Serv Res. 2024 Oct 11;24(1):1222. doi: 10.1186/s12913-024-11711-8.
3
Improving Cognitive Function with Nutritional Supplements in Aging: A Comprehensive Narrative Review of Clinical Studies Investigating the Effects of Vitamins, Minerals, Antioxidants, and Other Dietary Supplements.营养补充剂改善衰老相关认知功能：系统评价维生素、矿物质、抗氧化剂和其他膳食补充剂对认知功能影响的临床试验研究
Nutrients. 2023 Dec 15;15(24):5116. doi: 10.3390/nu15245116.
4
Dementia-related agitation: a review of non-pharmacological interventions and analysis of risks and benefits of pharmacotherapy.痴呆相关激越：非药物干预的综述及药物治疗的风险和获益分析。
Transl Psychiatry. 2017 Oct 31;7(10):e1250. doi: 10.1038/tp.2017.199.
本文引用的文献
1
Benzodiazepine use and risk of Alzheimer's disease: case-control study.苯二氮䓬类药物使用与阿尔茨海默病风险：病例对照研究。
BMJ. 2014 Sep 9;349:g5205. doi: 10.1136/bmj.g5205.
2
2014 Alzheimer's disease facts and figures.2014 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2014 Mar;10(2):e47-92. doi: 10.1016/j.jalz.2014.02.001.
3
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.西酞普兰对阿尔茨海默病激越的影响：CitAD 随机临床试验。
JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.
4
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.可能患有阿尔茨海默病的患者中，常规和非典型抗精神病药物的长期影响。
Am J Psychiatry. 2013 Sep;170(9):1051-8. doi: 10.1176/appi.ajp.2013.12081046.
5
Relapse risk after discontinuation of risperidone in Alzheimer's disease.阿兹海默病患者停用利培酮后的复发风险。
N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058.
6
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.美国老年医学学会更新了老年人潜在不适当药物使用的 Beers 标准。
J Am Geriatr Soc. 2012 Apr;60(4):616-31. doi: 10.1111/j.1532-5415.2012.03923.x. Epub 2012 Feb 29.
7
Antidepressants for agitation and psychosis in patients with dementia.用于治疗痴呆患者激越和精神病症状的抗抑郁药。
Am Fam Physician. 2012 Jan 1;85(1):20-2.
8
Risk of mortality among individual antipsychotics in patients with dementia.抗精神病药物治疗痴呆患者的死亡率风险。
Am J Psychiatry. 2012 Jan;169(1):71-9. doi: 10.1176/appi.ajp.2011.11030347. Epub 2011 Oct 31.
9
Neuropsychiatric symptoms in Alzheimer's disease.阿尔茨海默病的神经精神症状。
Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410.
10
Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.长期服用丙戊酸二钠以减轻阿尔茨海默病的躁动和临床进展。
Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.
Zotero 插件